{
    "eid": "2-s2.0-85124603840",
    "title": "Assisting Multitargeted Ligand Affinity Prediction of Receptor Tyrosine Kinases Associated Nonsmall Cell Lung Cancer Treatment with Multitasking Principal Neighborhood Aggregation",
    "cover-date": "2022-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Analytical Chemistry",
            "@code": "1602",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Chemistry (miscellaneous)",
            "@code": "1601",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Physical and Theoretical Chemistry",
            "@code": "1606",
            "@abbrev": "CHEM"
        },
        {
            "@_fa": "true",
            "$": "Organic Chemistry",
            "@code": "1605",
            "@abbrev": "CHEM"
        }
    ],
    "keywords": [
        "Affinity prediction",
        "Drug discovery",
        "Machine learning",
        "Multitasking",
        "Quantitative structure\u2013activity relationship (QSAR)"
    ],
    "authors": [
        "Fahsai Nakarin",
        "Kajjana Boonpalit",
        "Jiramet Kinchagawat",
        "Patcharapol Wachiraphan",
        "Thanyada Rungrotmongkol",
        "Sarana Nutanong"
    ],
    "citedby-count": 2,
    "ref-count": 83,
    "ref-list": [
        "Network pharmacology: The next paradigm in drug discovery",
        "Perspectives in the development of hybrid bifunctional antitumour agents",
        "Highlights in resistance mechanism pathways for combination therapy",
        "Hybrid Drugs\u2014A Strategy for Overcoming Anticancer Drug Resistance?",
        "Multi-target pharmacology: Possibilities and limitations of the \u201cskeleton key approach\u201d from a medicinal chemist perspective",
        "Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update",
        "Tyrosine kinase inhibitors in cancer: Breakthrough and challenges of targeted therapy",
        "Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations",
        "First-line crizotinib versus chemotherapy in ALK-positive lung cancer",
        "Crizotinib versus chemotherapy in advanced ALK-positive lung cancer",
        "CH5424802 (RO5424802) for patients with ALK-rearranged advanced non-small-cell lung cancer (AF-001JP study): A single-arm, open-label, phase 1\u20132 study",
        "Alectinib shows potent antitumor activity against RET-rearranged non\u2013small cell lung cancer",
        "Identifying and targeting ROS1 gene fusions in non\u2013small cell lung cancer",
        "Multi-target drugs: The trend of drug research and development",
        "A comparison of protein kinases inhibitor screening methods using both enzymatic activity and binding affinity determination",
        "High-throughput screening assay datasets from the pubchem database",
        "Computational Chemistry on a Budget: Supporting Drug Discovery with Limited Resources: Miniperspective",
        "Maximizing computational tools for successful drug discovery",
        "Deep Learning in Virtual Screening: Recent Applications and Developments",
        "QSAR-based virtual screening: Advances and applications in drug discovery",
        "QSAR modeling: Where have you been? Where are you going to?",
        "Molecular similarity concepts for informatics applications",
        "A novel multi-target drug screening strategy directed against key proteins of DAPk family",
        "Transfer and multi-task learning in QSAR modeling: Advances and challenges",
        "Multitasking models for quantitative structure\u2013biological effect relationships: Current status and future perspectives to speed up drug discovery",
        "Could graph neural networks learn better molecular representation for drug discovery? A comparison study of descriptor-based and graph-based models",
        "A Comprehensive Survey on Graph Neural Networks",
        "Molecular graph convolutions: Moving beyond fingerprints",
        "Stochastic gradient boosting",
        "MoleculeNet: A benchmark for molecular machine learning",
        "Graph neural networks: A review of methods and applications",
        "Enhanced Graph Isomorphism Network for Molecular ADMET Properties Prediction",
        "Principal Neighbourhood Aggregation for Graph Nets",
        "Adapted transfer of distance measures for quantitative structure-activity relationships and data-driven selection of source datasets",
        "Demystifying multitask deep neural networks for quantitative structure\u2013activity relationships",
        "Data set modelability by QSAR",
        "Molecule Property Prediction Based on Spatial Graph Embedding",
        "Toward Accurate Predictions of Atomic Properties via Quantum Mechanics Descriptors Augmented Graph Convolutional Neural Network: Application of This Novel Approach in NMR Chemical Shifts Predictions",
        "LigEGFR: Spatial graph embedding and molecular descriptors assisted bioactivity prediction of ligand molecules for epidermal growth factor receptor on a cell line-based dataset",
        "Beware of R 2: Simple, unambiguous assessment of the prediction accuracy of QSAR and QSPR models",
        "Principles of QSAR Modeling",
        "Beware of unreliable Q 2! A comparative study of regression metrics for predictivity assessment of QSAR models",
        "Prediction of pharmacological activities from chemical structures with graph convolutional neural networks",
        "XGraphBoost: Extracting Graph Neural Network-Based Features for a Better Prediction of Molecular Properties",
        "Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1",
        "Reconciling modern machine-learning practice and the classical bias\u2013variance trade-off",
        "Robust QSAR models using Bayesian regularized neural networks",
        "Applicability domains enhance application of PPAR\u03b3 agonist classifiers trained by drug-like compounds to environmental chemicals",
        "Large-scale modeling of multispecies acute toxicity end points using consensus of multitask deep learning methods",
        "Applicability domain for QSAR models: Where theory meets reality",
        "Applicability domain: Towards a more formal definition",
        "Deep learning enables rapid identification of potent DDR1 kinase inhibitors",
        "Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future",
        "On outliers and activity cliffs why QSAR often disappoints",
        "The Chemistry Development Kit (CDK) v2. 0: Atom typing, depiction, molecular formulas, and substructure searching",
        "PyBEL: A computational framework for Biological Expression Language",
        "End-to-end drug entity recognition and adverse effect relation extraction via principal neighbourhood aggregation network",
        "Multitask Learning: A Knowledge-Based Source of Inductive Bias",
        "Optuna: A Next-generation Hyperparameter Optimization Framework",
        "Beware of q2!",
        "Does rational selection of training and test sets improve the outcome of QSAR modeling?",
        "Comprehensive ensemble in QSAR prediction for drug discovery",
        "CarcinoPred-EL: Novel models for predicting the carcinogenicity of chemicals using molecular fingerprints and ensemble learning methods",
        "Discovery of Dual FGFR4 and EGFR Inhibitors by Machine Learning and Biological Evaluation",
        "Random Forests",
        "Scikit-learn: Machine Learning in Python",
        "Graph convolutional networks for computational drug development and discovery",
        "A Novel Graph Neural Network Methodology to Investigate Dihydroorotate Dehydrogenase Inhibitors in Small Cell Lung Cancer",
        "Hyperopt: A Python Library for Optimizing the Hyperparameters of Machine Learning Algorithms",
        "Activity cliffs in drug discovery: Dr Jekyll or Mr Hyde?",
        "Evolving concept of activity cliffs",
        "Exploring activity cliffs in medicinal chemistry: miniperspective",
        "Similarity-potency trees: A method to search for SAR information in compound data sets and derive SAR rules",
        "Comprehensive analysis of single-and multi-target activity cliffs formed by currently available bioactive compounds"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Rayong",
            "@id": "60110787",
            "affilname": "Vidyasirimedhi Institute of Science and Technology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60110787",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "School of Information Science and Technology",
        "VISTEC-depa Thailand Artificial Intelligence Research Institute",
        "Vidyasirimedhi Institute of Science and Technology"
    ]
}